Examining osteoprotective properties of gluten-free bread made with a combination of amaranth and tigernut flours (2024)

  • Adejuyigbe, B., Kallini, J., Chiou, D., and Kallini, J.R. (2023). Osteoporosis: molecular pathology, diagnostics, and therapeutics. International Journal of Molecular Sciences, 24(19): 14583, https://doi.org/10.3390/ijms241914583.

  • Alekhina, N.N., Ponomareva, E.I., Zharkova, I.M., and Grebenshchikov, A.V. (2018). Assessment of the bioavailability of minerals and antioxidant activity of the grain bread in the in vivo experiment. Russian Open Medical Journal, 7(4): e0409, https://doi.org/10.15275/rusomj.2018.0409.

  • Altman, A., Hochberg, Z., and Silbermann, M. (1992). Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse. Calcified Tissue International, 51(4): 298–304, https://doi.org/10.1007/BF00334491.

  • Anam, A.K. and Insogna, K. (2021). Update on osteoporosis screening and management. The Medical Clinics of North America, 105(6): 1117–1134, https://doi.org/10.1016/j.mcna.2021.05.016.

  • Anastasilaki, E., Paccou, J., Gkastaris, K., and Anastasilakis, A.D. (2023). Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management. Hormones (Athens, Greece), 22(4): 611–622, https://doi.org/10.1007/s42000-023-00491-1.

  • Angeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., and Giustina, A. (2006). High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone, 39(2): 253–259, https://doi.org/10.1016/j.bone.2006.02.005.

  • Avtandilov, V.V. (1990). Medical morphometry. Medicine Publishers, Moscow, 1990. (in Russian).

  • Baranova, I.A. and Baranova, I.A. (2008). Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment. Modern Rheumatology Journal, 2(1): 31–39, (in Russian) https://doi.org/10.14412/1996-7012-2008-455.

  • Batur, P. (2024). Osteoporosis update: screening and treatment recommendations. Journal of Women's Health, 33(3): 269–272, (2002), https://doi.org/10.1089/jwh.2023.0816.

  • Bavykina, I.A., Zvyagin, A.A., Gusev, K.Yu., Zharkova, I.M., and Miroshnichenko, L.A. (2016). The state of bone mineral density in children with gluten intolerance when using amaranth products. Issues of Practical Pediatrics, 11(1): 32–38, (in Russian).

  • Canalis, E., Mazziotti, G., Giustina, A., and Bilezikian, J.P. (2007). Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporosis International, 18(10): 1319–1328, https://doi.org/10.1007/s00198-007-0394-0.

  • Catarzi, S., Romagnoli, C., Marcucci, G., Favilli, F., Iantomasi, T., and Vincenzini, M.T. (2011). Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. Biochimica et Biophysica Acta, 1810(4): 446–456, https://doi.org/10.1016/j.bbagen.2011.01.005.

  • Cosman, F., Langdahl, B., and Leder, B.Z. (2024). Treatment sequence for osteoporosis. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 30(5): 490–496, https://doi.org/10.1016/j.eprac.2024.01.014.

  • Cui, Z., Meng, X., Feng, H., Zhuang, S., Liu, Z., Zhu, T., Ye, K., Xing, Y., Sun, C., Zhou, F., and Tian, Y. (2019). Estimation and projection about the standardized prevalence of osteoporosis in mainland China. Archives of Osteoporosis, 15(1): 2, https://doi.org/10.1007/s11657-019-0670-6.

  • Das, U.N. (2024). Is there a role for essential fatty acids in osteoporosis? European Journal of Clinical Nutrition, 78(8): 659–662, https://doi.org/10.1038/s41430-024-01456-2.

  • Dunford, J.E., Rogers, M.J., Ebetino, F.H., Phipps, R.J., and Coxon, F.P. (2006). Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases. Journal of Bone and Mineral Research, 21(5): 684–694, https://doi.org/10.1359/jbmr.060118.

  • Fadeev, S.B. and Volkov, D.V. (2002). Evaluating the severity of the experimental animal condition in a surgical experiment. In: Proceedings of the Scientific Conference Dedicated to the 25-Year Anniversary of City Clinical Emergency Hospital No. 1. Orenburg, p. 52, (in Russian).

  • Formosa, M.M., Christou, M.A., and Mäkitie, O. (2024). Bone fragility and osteoporosis in children and young adults. Journal of Endocrinological Investigation, 47(2): 285–298, https://doi.org/10.1007/s40618-023-02179-0.

  • Gehrke, B., Alves Coelho, M.C., Brasil d'Alva, C., and Madeira, M. (2023). Long-term consequences of osteoporosis therapy with bisphosphonates. Archives of Endocrinology and Metabolism, 68: e220334, https://doi.org/10.20945/2359-4292-2022-0334.

  • Gustinovich, V.G. (2020). Improvement of technology and development of a new assortment of functional flour-based confectionery products using fine vegetable powders, PhD Abstract. Voronezh, Russia, (in Russian).

  • Humphrey, M.B., Russell, L., Danila, M.I., Fink, H.A., Guyatt, G., Cannon, M., Caplan, L., Gore, S., Grossman, J., Hansen, K.E., Lane, N.E., Ma, N.S., Magrey, M., McAlindon, T., Robinson, A.B., Saha, S., Womack, C., Abdulhadi, B., Charles, J.F., Cheah, J.T.L., Chou, S., Goyal, I., Haseltine, K., Jackson, L., Mirza, R., Moledina, I., Punni, E., Rinden, T., Turgunbaev, M., Wysham, K., Amy, S., Turner, A.S., and Uhl, S. (2023). 2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis & Rheumatology (Hoboken, N.J.), 75(12): 2088–2102, https://doi.org/10.1002/art.42646.

  • Kędzia, G., Woźniak, M., Samborski, W., and Grygiel-Górniak, B. (2023). Impact of dietary protein on osteoporosis development. Nutrients, 15(21): 4581, https://doi.org/10.3390/nu15214581.

  • Lesnyak, O.M. (2011). Audit of the state of the osteoporosis in the Russian Federation. Preventive Medicine, 14(2): 7–10, (in Russian).

  • Merlijn, T., Swart, K.M.A., van der Horst, H.E., Netelenbos, J.C., and Elders, P.J.M. (2020). Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 31(2): 251–257, https://doi.org/10.1007/s00198-019-05226-w.

  • Morin, S.N., Feldman, S., Funnell, L., Giangregorio, L., Kim, S., McDonald-Blumer, H., Santesso, N., Ridout, R., Ward, W., Ashe, M.C., Bardai, Z., Bartley, J., Binkley, N., Burrell, S., Butt, D., Cadarette, S.M., Cheung, A.M., Chilibeck, P., Dunn, S., Falk, J., Frame, H., Gittings, W., Hayes, K., Holmes, C., Ioannidis, G., Jaglal, S.B., Josse, R., Khan, A.A., McIntyre, V., Nash, L., Negm, A., Papaioannou, A., Ponzano, M., Rodrigues, I.B., Thabane, L., Thomas, C.A., Tile, L., Wark, J.D., and for the Osteoporosis Canada 2023 Guideline Update Group (2023). Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update. CMAJ: Canadian Medical Association Journal, 195(39): E1333–E1348, https://doi.org/10.1503/cmaj.221647.

  • Muniyasamy, R. and Manjubala, I. (2024). Insights into the mechanism of osteoporosis and the available treatment options. Current Pharmaceutical Biotechnology, 25(12): 1538–1551, https://doi.org/10.2174/0113892010273783231027073117.

  • Papadopoulou, S.K., Papadimitriou, K., Voulgaridou, G., Georgaki, E., Tsotidou, E., Zantidou, O., and Papandreou, D. (2021). Exercise and nutrition impact on osteoporosis and sarcopenia – the incidence of osteosarcopenia: a narrative review. Nutrients, 13(12): 4499, https://doi.org/10.3390/nu13124499.

  • Ramchand, S.K. and Leder, B.Z. (2024). Sequential Therapy for the long-term treatment of postmenopausal osteoporosis. The Journal of Clinical Endocrinology and Metabolism, 109(2): 303–311, https://doi.org/10.1210/clinem/dgad496.

  • Ray, P.D., Huang, B.W., and Tsuji, Y. (2012). Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cellular Signalling, 24(5): 981–990, https://doi.org/10.1016/j.cellsig.2012.01.008.

  • Shepelkevich, A.P., Pekun, Yu.V, and Vasilyeva, NA (2023). Glucocorticoid-induced osteoporosis: current features of diagnosis and treatment, (in Russian), https://pharmacare.by/publications/endocrinology/glyukokortikoid-inducirovannyj-osteoporoz-osobennosti-diagnostiki-i-lecheniya-na-sovremennom-etape.html (Accessed 17 Apr 2023).

  • Shin, S., Sung, J., and Joung, H. (2015). A fruit, milk and whole grain dietary pattern is positively associated with bone mineral density in Korean healthy adults. European Journal of Clinical Nutrition, 69(4): 442–448, https://doi.org/10.1038/ejcn.2014.231.

  • Tanaka, Y., Soen, S., Hirata, S., Okada, Y., Fujiwara, S., Tanaka, I., Kitajima, Y., Kubota, T., Ebina, K., Takashi, Y., Inoue, R., Yamauchi, M., Okubo, N., Ueno, M., Ohata, Y., Ito, N., Ozono, K., Nakayama, H., Terauchi, M., Tanaka, S., and Fukumoto, S. (2024). The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. Journal of Bone and Mineral Metabolism, 42(2): 143–154, https://doi.org/10.1007/s00774-024-01502-w.

  • Thompson, K., Rogers, M.J., Coxon, F.P., and Crockett, J.C. (2006). Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Molecular Pharmacology, 69(5): 1624–1632, https://doi.org/10.1124/mol.105.020776.

  • van Staa, T.P., Leufkens, H.G., Abenhaim, L., Begaud, B., Zhang, B., and Cooper, C. (2000). Use of oral corticosteroids in the United Kingdom. QJM, 93(2): 105–111, https://doi.org/10.1093/qjmed/93.2.105.

  • Vorotnikova, S.Yu. and Pigarova, E.A. (2016). Zoledronic acid in the treatment of osteoporosis and other skeletal disorders. Osteoporosis and Bone Diseases, 19(3): 23–27, (in Russian), https://doi.org/10.14341/osteo2016323-27.

  • Wang, Y., Liu, J., Pang, Q., and Tao, D. (2017). Alpinumisoflavone protects against glucocorticoid-induced osteoporosis through suppressing the apoptosis of osteoblastic and osteocytic cells. Biomedicine and Pharmacotherapy, 96: 993–999, https://doi.org/10.1016/j.biopha.2017.11.136.

  • Wang, J., Xing, F., Sheng, N., and Xiang, Z. (2023). Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey. Osteoporosis International, 34(12): 2087–2100, https://doi.org/10.1007/s00198-023-06896-3.

  • Ward, L.M. (2024). A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence. Frontiers in Endocrinology, 14: 1266986, https://doi.org/10.3389/fendo.2023.1266986.

  • Xie, J., Li, S., Xiao, L., Ouyang, G., Zheng, L., Gu, Y., Gao, C., and Han, X. (2019). Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients. Journal of Orthopaedic Surgery and Research, 14(1): 421, https://doi.org/10.1186/s13018-019-1492-3.

  • Zharkova, I.M., Gustinovich, V.G., Samokhvalov, A.A., Koleva, T.N., Tikhonova, M.Yu., and Slepokurova, Yu.I. (2020). Patent for Invention RU 2718517 C1. Method for the production of gluten-free bread. Application No. 2019122617 of 18 July 2019. Published 08 April 2020. Bulletin 10. (in Russian).

  • Zvyagin, A.A., Bavykina, I.A., Zharkova, I.M., and Miroshnichenko, L.A. (2015). The potential of amaranth flour as a gluten-free product. Dietary Issues in Children, 13(2): 46–51, (in Russian).

    • Examining osteoprotective properties of gluten-free bread made with a combination of amaranth and tigernut flours (2024)
    Top Articles
    The Death of Notti Osama: An Unraveling Tale - 25Magazine
    The Despair of Generation “Notti Bop”
    Who Is Notti Osama? His Bio, Death, Girlfriend, Net Worth
    Latest Posts
    2024 Ford F-150 Raptor® in Redford, MI | Detroit Ford F-150 | Pat Milliken Ford
    Who is Notti Osama? What happened to Notti Osama?
    Recommended Articles
    Article information

    Author: Rubie Ullrich

    Last Updated:

    Views: 5583

    Rating: 4.1 / 5 (52 voted)

    Reviews: 83% of readers found this page helpful

    Author information

    Name: Rubie Ullrich

    Birthday: 1998-02-02

    Address: 743 Stoltenberg Center, Genovevaville, NJ 59925-3119

    Phone: +2202978377583

    Job: Administration Engineer

    Hobby: Surfing, Sailing, Listening to music, Web surfing, Kitesurfing, Geocaching, Backpacking

    Introduction: My name is Rubie Ullrich, I am a enthusiastic, perfect, tender, vivacious, talented, famous, delightful person who loves writing and wants to share my knowledge and understanding with you.